Trái phiếu BMYMP
Sau đây là danh sách trái phiếu doanh nghiệp Bristol-Myers Squibb Co.. Các nhà đầu tư thường lựa chọn trái phiếu của công ty vì tính ổn định cao hơn trong thời điểm thị trường biến động. Nghiên cứu giá cả, lợi suất và các số liệu thống kê khác và tìm khoản đầu tư đáng tin cậy.
Mã | Lợi suất đáo hạn % | Khối lượng | Giá % | Phiếu giảm giá % | Ngày đáo hạn | Giá trị dư nợ | Giá trị khuôn mặt | Giá trị mệnh giá tối thiểu | Bên phát hành |
---|---|---|---|---|---|---|---|---|---|
— | 20 K | 98.90% | 5.25% | 2043-08-15 | 218.37 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 15 K | 113.79% | 6.88% | 2097-08-01 | 62.42 M USD | 1,000.00 USD | 1,000.00 USD | Bristol Myers Squibb Co. | |
— | 355 K | 81.52% | 4.25% | 2049-10-26 | 3.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 5.07 M | 100.25% | 3.90% | 2028-02-20 | 1.45 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 5 M | 100.18% | 4.84% | 2026-02-20 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 10.71 M | 77.03% | 3.25% | 2042-08-01 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 783 K | 91.32% | 4.63% | 2044-05-15 | 744.72 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 1.32 M | 85.03% | 4.35% | 2047-11-15 | 1.24 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | — | 100 K | 79.04% | 4.63% | 2044-05-15 | 3.69 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 4 K | 103.13% | 6.80% | 2026-11-15 | 255.95 M USD | 1,000.00 USD | 1,000.00 USD | Bristol Myers Squibb Co. | |
— | 5.2 M | 99.51% | 3.20% | 2026-06-15 | 1.74 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 204 K | 88.02% | 1.45% | 2030-11-13 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 52 K | 87.24% | 4.55% | 2048-02-20 | 1.24 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | — | 25 K | 98.72% | 3.45% | 2027-11-15 | 16.55 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | — | 8 K | 87.60% | 5.00% | 2045-08-15 | 15.71 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 300 K | 107.25% | 5.88% | 2036-11-15 | 279.22 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 2.65 M | 90.66% | 4.13% | 2039-06-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 750 K | 95.71% | 3.40% | 2029-07-26 | 26.56 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 40 K | 94.75% | 5.00% | 2045-08-15 | 741.72 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 523 K | 99.47% | 3.45% | 2027-11-15 | 517.67 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 137.60% | 4.55% | 2048-02-20 | 9.5 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 141.76% | 5.00% | 2045-08-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 104.25% | 3.20% | 2026-06-15 | 5.95 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 122.76% | 4.13% | 2039-06-15 | 4.4 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 116.80% | 3.90% | 2028-02-20 | 6.07 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 11 K | 103.38% | 5.70% | 2040-10-15 | 151.01 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | — | 30 K | 82.51% | 5.25% | 2043-08-15 | 4.06 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 0 | 114.77% | 3.45% | 2027-11-15 | 67 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | — | 5 K | 80.09% | 4.35% | 2047-11-15 | 13.57 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 2.07 M | 97.90% | 3.40% | 2029-07-26 | 2.37 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | — | 20 K | 84.30% | 4.55% | 2048-02-20 | 37.2 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 2 K | 106.08% | 6.13% | 2038-05-01 | 219.25 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | — | 44 K | 99.57% | 3.90% | 2028-02-20 | 43.84 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 0 | 130.24% | 4.25% | 2049-10-26 | 500 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 2.53 M | 99.38% | 0.75% | 2025-11-13 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | — | 10 K | 93.18% | 5.70% | 2040-10-15 | 2.3 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 0 | 104.63% | 5.10% | 2031-02-22 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 98.83% | 3.25% | 2027-02-27 | 512.28 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 107.62% | 5.75% | 2031-02-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 101.33% | 4.90% | 2027-02-22 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 94.53% | 1.13% | 2027-11-13 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 73.86% | 3.70% | 2052-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 99.67% | 5.50% | 2044-02-22 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 88.25% | 4.50% | 2044-03-01 | 341.52 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 69.48% | 2.35% | 2040-11-13 | 750 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 59.47% | 2.55% | 2050-11-13 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 92.27% | 2.95% | 2032-03-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 109.61% | 6.40% | 2063-11-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 85.98% | 1.75% | 2035-05-15 | 575 M EUR | 1,000.00 EUR | 100,000.00 EUR | Bristol Myers Squibb Co. | |
— | 0 | 108.55% | 6.25% | 2053-11-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 103.23% | 5.20% | 2034-02-22 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 97.61% | 5.55% | 2054-02-22 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 97.33% | 5.65% | 2064-02-22 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 100.20% | 4.95% | 2026-02-20 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 72.57% | 3.90% | 2062-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 80.44% | 3.55% | 2042-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 108.99% | 5.90% | 2033-11-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 102.75% | 4.90% | 2029-02-22 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |